Floatz logo

DL-DOBUTAMINE

Hypoperfusion

Federal University of São PauloSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hypoperfusion cohort.

Asset / SponsorPhaseRating
REGADENOSON
University of Utah
N/AD
ADENOSINE
University of Utah
N/AD

Same molecule, other indications

DL-DOBUTAMINE is also rated in:

traumatic brain injuryDormant
CCC
Indicative ·
53 / 100
View asset →
infectious disease with sepsisDormant
CCC
Indicative ·
53 / 100
View asset →
HyperlactatemiaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →